ReviewAdvanced pharmaceutical bulletin2020

PCSK9: A Key Target for the Treatment of Cardiovascular Disease (CVD).

Saeideh Sobati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.